Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonalcoholic steatohepatitis.

P L M Jansen1

  • 1Department of Gastroenterology and Hepatology, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, the Netherlands. pljansen@amc.uva.nl

The Netherlands Journal of Medicine
|November 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of macrophages in the development of biliary injury in a lipopolysaccharide-aggravated hepatic ischaemia-reperfusion model.

Biochimica et biophysica acta. Molecular basis of disease·2017
Same author

Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment.

International journal of obesity (2005)·2015
Same author

Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.

The Netherlands journal of medicine·2014
Same author

Gallstone disease in severely obese children participating in a lifestyle intervention program: incidence and risk factors.

International journal of obesity (2005)·2014
Same author

Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir.

Scandinavian journal of gastroenterology·2012
Same author

Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy.

European journal of radiology·2010
Same journal

A diagnostic tool for self-poisoned patients: Analysis of gastric content and lavage fluids.

The Netherlands journal of medicine·2020
Same journal

Answer to Photoquiz A bone disorder with skin lesions.

The Netherlands journal of medicine·2020
Same journal

A bone disorder with skin lesions.

The Netherlands journal of medicine·2020
Same journal

Answer to Photoquiz A fascinating liver abscess.

The Netherlands journal of medicine·2020
Same journal

A fascinating liver abscess.

The Netherlands journal of medicine·2020
Same journal

Answer to Photoquiz A polyposis syndrome.

The Netherlands journal of medicine·2020
See all related articles

Nonalcoholic steatohepatitis (NASH) is a liver condition often linked to obesity and diabetes. Early detection and management focusing on insulin sensitivity are key to preventing progression to cirrhosis.

Area of Science:

  • Hepatology
  • Metabolic Diseases
  • Gastroenterology

Context:

  • Nonalcoholic steatohepatitis (NASH) is an underdiagnosed liver condition.
  • Characterized by steatosis, necroinflammation, and fibrosis, NASH can progress to cirrhosis and hepatocellular carcinoma.
  • It is highly prevalent in individuals with obesity and type 2 diabetes mellitus.

Purpose:

  • To define Nonalcoholic steatohepatitis (NASH) and its precursor, Nonalcoholic fatty liver (NAFL).
  • To identify key etiological factors and associated conditions.
  • To outline potential therapeutic strategies.

Summary:

  • Nonalcoholic fatty liver (NAFL) is the primary cause of elevated serum liver enzymes in the general population.
  • Insulin resistance is a significant etiological factor in the development of NASH.

Related Experiment Videos

  • Potential therapies include weight loss, physical exercise, and medications that enhance insulin sensitivity.

    • Impact:

    • Highlights the prevalence and serious potential outcomes of NASH.
    • Emphasizes the role of metabolic factors like insulin resistance.
    • Suggests lifestyle modifications and pharmacological interventions for NASH management.